Open access
Jul 2026
Lymphoid Tissue-Activated Donor T cells (LADTs) for Improved Donor Lymphocyte Infusion (DLI) against Blood Cancers 2250463
The feasibility of LADT generation and the proof-of-concept of using LADTs for improved DLI are demonstrated and the cellular immunotherapy approach does not depend on cancer-specific biomarkers thus may be applied to a wide range of hematopoietic malignancies.
Yasemin Kuş, K. Christie, Shen-Yu Zhang et al.
· Journal of Immunology · 0 citations